Boehringer Ingelheim's Ben Venue laboratories facility in Ohio is to cease contract manufacturing activities and focus on generics operations. Contract manufacturing work will be transitioned to other Boehringer plants over the next few years.
Nasdaq
Monday 22 August 2011
BI plant to exit contract manufacturing
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment